Wang’s team development a small molecule agonist ZG111 of the mitochondrial caseinolytic protease P (ClpP) that produces tumor inhibitory effects in pancreatic cancer cell lines and mouse models [49]. Here, CLPP is linked to pancreatic neoplasm.